Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Teratogenicity01:07

Teratogenicity

2.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Short Report: An Examination of Children's Autism Traits and Their Association With Family Experience.

Autism research : official journal of the International Society for Autism Research·2026
Same author

Mental health disorders and suicide risk among autistic children, adolescents and adults: a population-based study using linked administrative data.

Lancet regional health. Americas·2026
Same author

Human germline biallelic loss-of-function <i>OSMR</i> variants cause severe allergic disease.

Journal of human immunity·2026
Same author

A computational model for quantifying instability of tandem repeats across the genome.

bioRxiv : the preprint server for biology·2026
Same author

Basic Science and Pathogenesis.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Optimizing the Better Nights, Better Days for Children with Neurodevelopmental Disorders program for large scale implementation.

Frontiers in sleep·2025

Related Experiment Video

Updated: Jun 25, 2025

The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders
19:57

The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders

Published on: August 5, 2017

8.4K

Risk and Resilience Variants in the Retinoic Acid Metabolic and Developmental Pathways Associated with Risk of FASD

Leo McKay1, Berardino Petrelli1, Molly Pind1

  • 1Department of Biochemistry & Medical Genetics, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.

Biomolecules
|May 24, 2024
PubMed
Summary

Fetal Alcohol Spectrum Disorder (FASD) is linked to prenatal alcohol exposure (PAE). Genetic variants in alcohol metabolism and retinoic acid (RA) pathways may explain FASD risk and resilience.

Keywords:
FASDFASD risk outcomesPAEbiomarkersfetal alcohol spectrum disordergenetic variantsprenatal alcohol exposurerare neurodevelopmental disordersretinoic acidwhole exome sequencing

More Related Videos

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
11:01

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats

Published on: December 14, 2014

9.7K
Assessing Teratogenic Changes in a Zebrafish Model of Fetal Alcohol Exposure
10:07

Assessing Teratogenic Changes in a Zebrafish Model of Fetal Alcohol Exposure

Published on: March 20, 2012

26.3K

Related Experiment Videos

Last Updated: Jun 25, 2025

The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders
19:57

The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders

Published on: August 5, 2017

8.4K
Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats
11:01

Moderate Prenatal Alcohol Exposure and Quantification of Social Behavior in Adult Rats

Published on: December 14, 2014

9.7K
Assessing Teratogenic Changes in a Zebrafish Model of Fetal Alcohol Exposure
10:07

Assessing Teratogenic Changes in a Zebrafish Model of Fetal Alcohol Exposure

Published on: March 20, 2012

26.3K

Area of Science:

  • Neuroscience
  • Genetics
  • Developmental Biology

Background:

  • Fetal Alcohol Spectrum Disorder (FASD) is a prevalent neurodevelopmental disorder in North America, affecting 2-5% of the population.
  • Prenatal alcohol exposure (PAE) is the primary cause, but the underlying genetic factors remain largely unknown.
  • Retinoic acid (RA) signaling is crucial for development and may be disrupted by PAE.

Purpose of the Study:

  • To investigate the genetic underpinnings of FASD by analyzing genes involved in RA metabolism and signaling pathways.
  • To identify genetic variants associated with risk and resilience in individuals diagnosed with FASD.
  • To explore the role of PAE-induced RA deficiency in FASD etiology.

Main Methods:

  • Candidate gene approach using whole exome sequencing data from 23 individuals with FASD.
  • Analysis of genetic variants in alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) genes.
  • Examination of variants in RA-regulated developmental pathway genes (e.g., SHH, WNT) and genes associated with comorbid neurodevelopmental disorders.

Main Results:

  • Identified risk and resilience alleles in ADH and ALDH genes, suggesting PAE disrupts RA production via alcohol metabolism.
  • Found significant variants in RA-regulated developmental pathways, including SHH and WNT.
  • Detected variants in genes linked to rare neurodevelopmental disorders with FASD comorbidities (STRA6, SOX9, FDG1, TBX1).

Conclusions:

  • PAE-induced RA deficiency is a significant etiological factor in FASD.
  • Genetic variants in RA metabolic and developmental pathways may serve as biomarkers for FASD risk and outcomes.
  • Further research is warranted to validate these findings in larger cohorts.